UTI Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

UTI Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹500 & Lump. ₹5000

AUM (Fund size)

1,144 Cr

Lock In Period

N/A

Expense Ratio

2.3

Exit Load

1% if less than 30 days, Nil if greater then or equals to 30 days.

Benchmark

BSE Healthcare Total Return

Summary

UTI Healthcare Fund Growth NAV is ₹305.9795 as of 17 May, 2026. UTI Healthcare Fund Growth has delivered 105.41% returns since its launch. The minimum SIP investment amount in UTI Healthcare Fund Growth is ₹500. The AUM of UTI Healthcare Fund Growth is ₹1,144 Cr. The expense ratio of the fund is 2.3%, and its benchmark is BSE Healthcare Total Return. The current exit load of the fund is 1% if less than 30 days, Nil if greater then or equals to 30 days.. In the last 1M months, UTI Healthcare Fund Growth has delivered 9.90% returns.

UTI Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M9.901.0111.38
6M5.981.669.62
1Y13.245.3417.07
3Y27.1217.02117.52

Portfolio Analysis

  • Equity: 98.67%
  • Debt: 1.32%
  • Others
As on: 2026-03-31
View allocation % by

1. SUN PHARMACEUTICALS INDUSTRIES9.99%
2. AJANTA PHARMA LTD.6.40%
3. LUPIN LTD.5.92%
4. GLENMARK PHARMACEUTICALS LTD.4.04%
5. GLAND PHARMA LTD.3.46%
6. DR REDDYS LABORATORIES LTD.3.45%
7. DIVIS LABORATORIES LTD.3.42%
8. ALKEM LABORATORIES LTD3.41%
9. AUROBINDO PHARMA LTD.2.98%
10. COHANCE LIFESCIENCES LIMITED2.76%
11. IPCA LABORATORIES LTD.2.38%
12. ANTHEM BIOSCIENCES LTD2.32%
13. PROCTOR & GAMBLE HEALTH LTD2.27%
14. SUDEEP PHARMA LIMITED2.14%
15. SAI LIFE SCIENCES LTD2.11%
16. CAPLIN POINT LABORATORIES LTD2.07%
17. VIYASH SCIENTIFIC LTD1.90%
18. ERIS LIFESCIENCES LTD1.84%
19. CIPLA LTD.1.74%
20. PFIZER LIMITED1.72%
21. MARKSANS PHARMA LTD.1.69%
22. WINDLAS BIOTEC LTD1.16%
23. EMCURE PHARMACEUTICALS LTD1.05%
24. AARTI PHARMALABS LTD0.84%
25. JUBILANT PHARMOVA LIMITED0.69%
26. BIOCON LTD.0.68%
27. SYNGENE INTERNATIONAL LTD.0.66%
28. ACUTAAS CHEMICALS LIMITED0.61%
29. ALEMBIC PHARMACEUTICALS0.52%
30. ORCHID PHARMA LTD.0.46%

1. APOLLO HOSPITALS ENTERPRISE LT3.73%
2. FORTIS HEALTHCARE LTD.3.01%
3. MAX HEALTHCARE INSTITUTE LTD2.63%
4. JUPITER LIFE LINE HOSPITALS LTD2.19%
5. ASTER DM HEALTHCARE LTD2.06%
6. GLOBAL HEALTH LTD.1.92%
7. METROPOLIS HEALTHCARE LTD1.59%
8. RAINBOW CHILDRENS MEDICARE LTD1.59%
9. KRISHNA INSTITUTE OF MEDI SCIE1.36%
10. DR LAL PATHLABS LTD.1.24%
11. VIJAYA DIAGNOSTIC CENTRE LTD1.08%

About Fund UTI Healthcare Fund Growth

UTI Healthcare Fund Growth managed by UTI Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹1,144 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.3. Under the expert guidance of Kamal Gada ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Kamal Gada

Mr. Kamal Gada is B.com, CA, CS, & CFA. Prior to joining UTI Mutual Fund he has worked with BPCL as Senior Accounts Officer.

Peer Comparison

Fund Name1Y3Y
This FundNippon India Pharma Fund Growth9.904790.8171
This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth13.218494.5962
This FundMirae Asset Healthcare Fund Growth15.3871101.8531
This FundSBI Healthcare Opportunities Fund Growth11.238102.7061
This FundUTI Healthcare Fund Growth13.2403105.4054

UTI Healthcare Fund Growth FAQs

UTI Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of UTI Healthcare Fund Growth is 2.3. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

UTI Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 9.90%
  • 6 Months : 5.98%
  • 1 Year : 13.24%
  • 3 Years : 27.12%
Returns of UTI Healthcare Fund Growth are updated daily based on NAV of ₹ 305.9795 as on May 15,2026. Since inception, the return has been 105.41%.

You can invest in UTI Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of UTI Healthcare Fund Growth is ₹1,144 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in UTI Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.